Source: British Cardiovascular Society
Follow this link for Full Text
Date of publication: 9th April 2021
Publication type: Research
In a nutshell: An FDA review of study findings showed a potential increased risk of cardiac arrhythmias in patients with pre-existing cardiac disease who are taking lamotrigine. FDA reviewed in vitro studies of lamotrigine after receiving reports of abnormal electrocardiographic findings, chest pain, loss of consciousness and cardiac arrest.
Length of publication: 1 webpage
Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library. https://www.hlisd.org/
Acknowledgement: Home | BCS (britishcardiovascularsociety.org)